Professor claims Eli Lilly's tirzepatide could essentially eradicate type 2 diabetes

Eli Lilly’s tirzepatide is ”a new start” within type 2 diabetes and could essentially eradicate the disease, professor Sten Madsbad, who is a consultant at the endocrinology department at Hvidovre hospital, tells Danish journal Sundhedspolitisk Tidsskrift.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Eli Lilly squares up to Novo Nordisk on obesity market
For subscribers